In 2008, the Spanish Society of Pulmonology (SEPAR) published the first guidelines in the world on the diagnosis and treatment of bronchiectasis. Almost 10 years later, considerable scientific advances have been made in both the treatment and the evaluation and diagnosis of this disease, and the original guidelines have been updated to include the latest therapies available for bronchiectasis. These new recommendations have been drafted following a strict methodological process designed to ensure quality of content, and are linked to a large amount of online information that includes a wealth of references. The guidelines are focused on the treatment of bronchiectasis from both a multidisciplinary perspective, including specialty areas and the different healthcare levels involved, and a multidimensional perspective, including a comprehensive overview of the specific aspects of the disease. A series of recommendations have been drawn up, based on an in-depth review of the evidence for treatment of the underlying etiology, the bronchial infection in its different forms of presentation using existing therapies, bronchial inflammation, and airflow obstruction. Nutritional aspects, management of secretions, muscle training, management of complications and comorbidities, infection prophylaxis, patient education, home care, surgery, exacerbations, and patient follow-up are addressed.
Keywords: Agudizaciones; Antibióticos inhalados; Bronchiectasis; Bronquiectasias; Chronic bronchial infection; Computed tomography; E-FACED; Exacerbations; FACED; Fisioterapia respiratoria; Infección bronquial crónica; Inhaled antibiotics; Macrolides; Macrólidos; Mucolytics; Mucolíticos; Pseudomonas aeruginosa; Respiratory physiotherapy; Tomografía computarizada.
Copyright © 2017 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.